| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 90.47B | 81.97B | 94.82B | 91.17B | 90.80B |
| Gross Profit | 33.74B | 30.46B | 35.15B | 34.19B | 35.28B |
| EBITDA | 15.50B | 14.62B | 35.57B | 16.07B | 16.41B |
| Net Income | 2.94B | 4.32B | 28.85B | 4.20B | 5.12B |
Balance Sheet | |||||
| Total Assets | 476.41B | 476.56B | 447.75B | 434.77B | 436.32B |
| Cash, Cash Equivalents and Short-Term Investments | 23.17B | 21.03B | 14.08B | 11.61B | 22.89B |
| Total Debt | 98.29B | 99.47B | 74.90B | 74.34B | 68.25B |
| Total Liabilities | 160.18B | 157.89B | 122.98B | 118.83B | 112.15B |
| Stockholders Equity | 259.58B | 258.30B | 268.13B | 258.46B | 266.95B |
Cash Flow | |||||
| Free Cash Flow | 8.96B | 6.05B | 6.32B | 4.73B | 7.45B |
| Operating Cash Flow | 14.55B | 10.46B | 9.92B | 8.16B | 11.66B |
| Investing Cash Flow | -1.70B | -14.60B | 13.03B | -17.54B | -6.34B |
| Financing Cash Flow | -12.32B | 12.62B | -21.73B | -1.40B | -12.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$22.41B | 2.84 | 6.12% | 5.00% | 2.39% | 7.81% | |
67 Neutral | HK$104.27B | 28.96 | 1.14% | 5.26% | 10.37% | -29.03% | |
66 Neutral | HK$381.08B | 5.51 | 5.53% | 5.15% | 2.24% | 1.42% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$252.59B | 17.13 | 2.12% | 4.02% | -0.47% | -30.71% | |
60 Neutral | HK$40.05B | 7.30 | 5.66% | 4.94% | 3.77% | -1.53% | |
42 Neutral | HK$33.62B | -1.40 | -21.69% | 0.44% | -9.73% | -440.87% |